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Introduction 
The marine bioactive compounds or Marine natural products (MNPs) offer avenues for 
developing cost-effective, safe and potent novel drugs and other useful products. MNPs are 
organic compounds produced by microbes, sponges, seaweeds, and other marine 
organisms. The host organism biosynthesizes these compounds as non-primary or 
secondary metabolites to protect themselves and to maintain homeostasis in their 
environment. In the decade from 1977 to 1987, around 2500 new metabolites (MNPs) were 
reported from marine organisms ranging from microbes to fish. According to Dr. S.Z. 
Qasim, . less than 1.0% of the total marine organisms have only been examined for MNPs 
research. Perusal of literature indicated that even the seawater has bactericidal properties. 
This could be attributed to the production of antibiotics by planktonic algae and bacteria 
respectively. ConSidering such vast resource, holistic approach of pharmacological research 
has to be given to develop potent therapeutics. 
Marine bacteria 
The discovery of penicillin in 1929 heralded the era of antibiotics, which led to the 
understanding that microorganisms are a rich source of useful natural products. Since that 
time and consequent to the continuous effort of R&D projects with heavy investments, 
nearly 50,000 natural products have been discovered from microorganisms. Of these 
substances, more than 10,000 are biologically active and more than 8000 are antibiotics. 
More than 100 microbial products are in use today as antibiotiCS, anti-tumor agents and 
agrochemica ls. It is demonstrated that marine bacteria produce anti-microbial substances. 
Further array of research results indicated that the marine microorganisms are capable of 
producing potent and unusual bioactive natural products that are uncommon in terrestrial 
microbes. 
The first documented identification of a bioactive marine bacterial metabolite was 
the highly brominated pyrrole antibiotiC, isolated by Burkholder and co-workers from a 
bacterium obtained from the surface of the Caribbean Sea grass. Subsequently, this unique 
metabolite was identified by x-ray crystallographic methods, which composed of more than 
70% bromine by weight. The metabolite exhibited impressive in vitro antibiotic properties 
against Gram-positive bacteria, with minimum inhibitory concentration (MIC) ranging from 
0.0063 to 0.2 ~g/ml. However, it was inactive for Gram-negative bacteria and animal 
assays. 
As more evidence is obtained, it is becoming abundantly clear that bacteria form 
highly specific, symbiotic relationships with marine plants and animals. Experience in this 
area arose from a study of the pathogen resistance of the estuarine shrimp Palaemon 
macrodactylus. The eggs of P. dactylus possess significant bacterial epibionts, which, when 
removed by treatment with antibiotics, leads to the rapid infestation of the eggs by 
pathogenic fungi, especially of lilgenidium callinectes. Although there are many plausible 
mechanisms to explain this protective phenomenon, with Palaemon it could be anti-fungal 
agents produced by bacteria. 
Although terrestrial fungi have represented a major biomedidnal resource (penicillin 
from Penicillium, for example), studies to develop the biomedicinal potential of marine fungi 
have been few. The isolation of a small lactone, leptosphaerin from Leptosphaeria oraemaris 
by Schiehser in1980 demonstrated that marine fungi may form important resource for 
unique metabolites. Later, the useful chemical, Gliovictin was isolated from marine fungus, 
Asteromyces cruciatus. Since then more than twenty useful bioactive compounds have been 
derived from marine fungi. 
Marine Micro algae 
Micro algae are Significant resource for bioactive metabolites, particularly cytotoxiC 
agents with applications in cancer chemotherapy. From the marine micro algae such as from 
the blooms of Phaeocystis sp., antibiotic substances are reported. Phaeocystis pouchetii 
produces chemicals such as Acrylic aCid, which constitutes about 7.0% of the dry weight. 
The antibiotiC substances thus produced are transferred throughout the food chain and 
found in the digestive tract of Antarctic penguins. Production of ~ carotene and vitamins by 
the halo tolerant alga Dunaliella sp., is documented. 
Marine Macro algae 
It is reported that of the total marine algae so far evaluated, 25% showed one or 
the other biological activity. Metabolites' of green algae were reported to contain 1,4 -
diacetoxic butadiene mOiety, which exhibited icthyotoxic property. Antimicrobial diterpene 
(dictyodiol) was isolated from Dictyota spinulosa. Both icthyotoxic as well as cytotoxiC 
diterpenoids from Dictyota sp. Among the red algae, halogenated lipids have been isolated, 
particularly from the Laurencia sp. The rare chemical prostaglandin was also reported to 
occur in Gracilaria pichenoids. Ulva meal supplementation was found to provide disease 
resistance to red sea bream in Japan. Similar results were also reported from Japan on the 
use of Ulva meal supplementation towards disease resistance and high growth rate in black 
sea bream. The polysaccharide fractions from marine algae, Porphyra yezoensis (PASF) was 
found to stimulate the in vivo and in vitro murine phagocytic function. The purified fractions 
of PASF gave stronger phagocytic activity. 
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An antiviral compound, UF-131 was isolated from the green alga Ulva fasciata. 
Extracts of caulerpa tax/folia and Ulva fasciata with moderate antiviral activity was found to 
protect the animals. Among the 30 different species of algae collected and screened for 
activity biological activity was recorded in 26 species towards bacteria. Growth of gram~ 
negative bacteria such as Vibrio and Staphylococcus and gram-positive bacteria such as 
Bacillus sp were found to be inhibited to varying degrees. Several species of Halinida 
produce terpenic di or tri aldehydes with icthyotoxic activity. In addition, brominated 
aromatics, nitrogen heterocycles, nitrogen-sulfur heterocycle, sterols, terpenes, 
dibutenoloides, protein, peptides and sulfated polysaccharides were also reported. The 
sulphated polysaccharides grouped as carrageenens and agar isolated from red and brown 
algae were shown to possess antigenic properties and exhibited anticoagulant and antiviral 
activities. Other compounds from algae were shown to possess antifungal, antibacterial, 
icthyotoxic, hypotensive and antihelminthic activities. 
Under the lCAR Ad-hoc scheme sanctioned by the Council, baSic data on the 
availability of different algae along the coasts of India with their secondary metabolite 
capabilities were carried out in CMFR!. Seventeen potential macro algal extracts were 
prepared and their bioactivity profiles were studied. Among the macro algal crude extracts, 
experiments conducted with pathogenic challenge among fISh and shellfISh indicated their 
potential therapeutic nature. The responses of the fish/shellfish towards treatment with a 
few of the algal metabolites have been also standardized in CMFR! laboratory. 
Marine Sponges 
In sponges, the secondary metabolites are synthesized to protect themselves and to 
maintain homeostasis. The wider biosynthetic capability of sponges could be attributed to 
their biological association with other symbionts. According to Bertrand and Vacelet, about 
38% of the sponge body comprises of microorganisms. A wide variety of secondary 
metabolites were isolated from sponges and these have been associated with antibacterial, 
antimicrobial, antiviral, antifouling, HIV-protease inhibitory, HIV reverse transcriptase 
inhibitory, immuno- suppressent and cytotoxiC activities. In addition to potential anticancer 
applications, the MNPs of sponges have a myriad of activities ranging from antibiotic activity 
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During the 19705 and 19805, investigators also studied the type and specificity of 
sponge-microbe assodations, often using microscopy to show the presence of specific 
symbiont morphologies within speCific sponges. The molecular basis of symbiosis was also 
probed, albeit to a lesser extent. Bacteria, which live symbiotically with sponges, can be 
passed through their feeding chambers without being digested. This suggested some sort of 
encapsulation or recognition process. In the demosponge Halichondria panicea, an 
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association with the microbe Pseudomonas inso/ifiJ may be lectin-based. An immunological 
basis for symbiosis in some sponges is claimed as evidence of a Precambrian origin for 
many symbioses. 
A major problem with the early studies on sponge-microbe symbiosis was that most 
microorganisms were uncultured or uncultivable, so descriptions of symbioses usually relied 
either on morphology of symbionts or chemical measurements of nutrient transfer. Even in 
the cases where putative symbionts could be cultured, the ecological relevance of symbiosis 
could not be determined. The period following Wilkinson's review has been marked by the 
ascendance of molecular biological techniques in environmental microbiology, which have 
allowed investigators to focus on uncultured microorganisms. 
that could not have been obtained by classical microbiological methods. The discovery of a 
member of the Archaea living specifically within a sponge similar to Axine//a mexicana was a 
particularly exciting. The archaeal microorganism, Cenarchaeum symbiosum (P: 
Crenarchaeota), lives at a relatively cold 10°C and is therefore considered sychrophilic. 
Subsequent in situ hybridization experiments showed which microorganism in the sponge 
was archaeal and allowed localization of the symbiont. 
Unfortunately, despite the scientific and technological benefits of determining the 
source organisms of interesting and bioactive metabolites, a microbial origin of sponge 
compounds has rarely been demonstrated. Most of the literature is purely speculative, 
based on similarities, however slight, between compounds from sponges and those from 
cultivated microorganisms, especially cyanobacteria. Several researchers have attempted to 
culture microorganisms from invertebrates in the hopes of obtaining some of these bioactive 
compounds. Although they have been successful in the discovery of novel natural products, 
this research has rarely demonstrated the presence of sponge metabolites in the microbial 
isolates. In one case the same compound was found in a Hyate//a sp. sponge as in a Vibrio 
sp. cultured from that sponge. These results demonstrate that traditional culturing 
approaches are not generally applicable to the environmental problems of sponge-microbe 
symbiosis. Two cases of symbiont production of sponge compounds have been clearly 
established. Both studies relied on cell fixation and physical separation techniques, 
bypaSSing the problem of culturing symbiotic microorganisms. Unson separated 
cyanobacterial symbionts from the sponge Dysidea herbacea by flow cytometry and showed 
that chlorinated amino acid derivatives cou ld only be found in the cyanobacterial fraction, 
while terpenes were localized in the sponge cell fraction. 
Sponges contain a standing population of bacteria inside; in some instances, the 
bacterial load may come up to 38% of the total volume of sponge. The bacterial population 
is seen even in the motile larval stages. How and when this bacterial population gets into 
the larvae of sponges in not known. It is believed that the sponge phagocytoses these 
bacteria when food becomes scarce. It is not sure where the various bioactive substances in 
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sponges are produced by the sponge itself or by the associate or through the combined 
action of both. 
Avenues for further research and development: 
Perusal of literature indicates that during the last three decades number of diverse 
biologically active compounds has been isolated from marine organisms, but the number of 
compounds taken-up for the field trial/clinical use are scanty. This may be due to the failure 
of successful collection of concerned source organism in bulk, which have same sort of 
secondary metabolites. Some of the future requirements are listed below: 
Microbial Isolation/screening and culture techniques: 
As the symbiotic microbes are difficult to culture under laboratory conditions, basic 
Research in Marine Microbiology is essential. Without considerable attention to developing 
the basic biology of marine microorganisms, explorations for new bioactive metabolites 
would be limited to those few classes of microorganisms, which are readily isolated and 
grown under "standard" conditions. Unfortunately, little is known about the specific 
nutrients and growth factors required by most of the marine microbes. For example, the 
common media components such as peptone, sugars etc., are unrealistic marine nutrients 
as complex carbon sources such as chitin, sulphated polysaccharides, marine protein etc., 
are found in the marine habitat. In addition, information is lacking on some of the 
uncommon inorganic elements such as lithium, silicon etc., abundant in the marine 
sediments. As a result of these difficulties, it is seen that less than S% of the available 
microbial population is only cultivable under the standard laboratory conditions. Presently, 
this condition, certainly limits the scope and ability to isolate and culture majority of the 
interesting and new microbes. 
Prepalation of crude extracts for bioactivity: 
As the goal is to obtain the widest possible screening for each crude extract so that 
no useful compound is over looked. Solvents such as methanol, chloroform or ether as 
independent solvents or as combinations can be used depending upon the nature of the 
MNPs. As soon as the crude extracts are obtained, there is need for immediate and simple 
ir vitm ,.... c~\~ ., 'ch as: i. A! l'i"1icrohial and ii. E'1zyme inhihition assay (very low quantity of 
sample only IS reqUired). '1 nlS In turn helps In the . bioassay - gUided fractionation and 
purification' process. 
Purification: 
Once bioactivity is detected in the crude extract, the next step is to purify the same. It is 
important to employ non-destructive method such as spectroscopiC method, which 
conserves the materials for further bioassays. In addition, techniques such as: TLC, 
MS/IR/uv and H nMR - (for structural elucidations) are to be adopted for purification of the 
crude extract and for determining the structure. 
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Phannacological screening: 
The next step after purification and structural elucidation is pharmacological 
screening. Studies such as determining the LDso of the extracts in mice, in addition to brine 
shrimp assay, fertilized sea urchin assay and starfish assay are to be carried out in 
established laboratories. Further tests such as: antiviral (AIDS/anti-HIV), cytotoxiC, anti-
inflammatory, anti-tumor, tumor promoter (protein kinase), analgesic, anti-coagulant / anti-
thrombic (ex: heparin), anti-ulcer, anti-cholesterol I anti-lipemic, wound dressing, anti-
paraSitic, anti-protozoa are to be conducted. 
Commercial development of bioactive (MNP) products: 
The · co-operative drug development programme' as suggested by Faulkner (1993) 
is the best method, which will solve the problems arising on issues such as: patent rights, 
academic freedom and industrial secrecy. 
Conservational aspects of source organisms: 
Eco-friendly collection of the source organism and required supply of them in bulk 
for scaling-up process. 
The role of Industry and Academia: 
Considering the less microbiological and intensive pharmacological training to the 
industrial personnel, relevant microbiological training has to be imparted to the industrial 
pharmacologists. New isolation methods, media development etc., are to be included in the 
curricula of academiC/research institutes. Collaborative programmes which combine 
biomedical and microbiological expertise of the pharmaceutical industry with the marine 
resources available in the marine R&D Institutes will in the long run help in the better 
utilization of the marine organisms or resources for biotechnological aspects. 
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DEVELOPMENTAL PROCESS IN MARINE PHARMACEUTICALS 
PRIMAR Y ISOLA TION 
I 
SPECIFIC ACTIVITY SCREENING 
Unique or potemially useful biologicals 
! 
SOURCE MA TERlALS 
Bulk collection of source materials to isolate characterize the active compounds 
! 
IN VIVO ACTIVITY SCREENING 
Tests to determine relative toxicity ant activity in animals , 
PURIFICA nON AND CHARCTERISA TION 
Bioassay guided purification and structural elucidation 
! 
PHARMACOLOGICAL STUDIES 
Testing for drug activity and safety 
i 
SCALING-UP PROCESS 
Chemical or Biosynthesis 
GOVERNME~~ALAPPROVAL 
Disclosure of complete drug source and manufacturing information, 
preclinical results and future research plans 
V 
CLIN ICAL EVALUATION 
Testing with human volunteers to determine metabolism, 
absorption, elimination, side effects, safe dose range 
and method of administration. 
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Mollusc foot adherence assay 
Assay plate Seawater 
A B~ 
~ Palella vu/gala 
C rki-" "'-7-\--'~Glass surface 
I 5min 
o 
Spread O+-- Shrunk foot 
Figure I. Procedure of the foot adherence assay: 
A. Preparation of the assay plate with 1 ml of selected concentration of 
extract/fraction. 
B. Riled with seawater without disturbance to the extract layer 
C. The limpets were removed carefully from the tank and introduced in to the 
triplicate experimental plate and kept on an illuminated glass surface to observe 
the foot reflex. 
D. Based on the foot adherence or shrinkage, the fouling rate can be estimated 
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